SutroVax
SutroVax is an independent vaccine platform in California that focuses on delivering conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.
5
Funding Rounds
$425.0m
Money raised
Overview
SutroVax is an independent vaccine platform in California that focuses on delivering conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.
- Website:
- Business model: B2C
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| As**** Kh**** | - | - | - |
Funding series
Funding Series Analysis
The company SutroVax has raised a total of $60m in funding over 5 rounds.
Key Insights:
- SutroVax Series B round, March 2017: $60m
- SutroVax funding round, June 2018: $85m
- SutroVax Series D round March 2020: $110m
- SutroVax, Inc. funding round, April 2020: $110m
- SutroVax funding round, March 2017: $60m
SutroVax Series B round, March 2017
$60m
SutroVax funding round, June 2018
$85m
SutroVax Series D round March 2020
$110m
SutroVax, Inc. funding round, April 2020
$110m
SutroVax funding round, March 2017
$60m
Industries
SutroVax is active in the following industries:
- Biotechnology
- Antigen
- Healthcare
- Vaccine
- Biopharmaceutical
- Technology
- Biology